
Ningbo Menovo Pharmaceutical Co., Ltd.
SSE:603538.SS
15.24 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 585.428 | 456.042 | 791.943 | 421.787 | 235.669 | 342.258 | 369.95 | 258.552 | 125.161 | 99.55 | 185.052 | 119.469 | 63.739 | 128.496 |
Short Term Investments
| 154.439 | 268.647 | 217.378 | 371.377 | 133.143 | 100.599 | -2.198 | -19.417 | -3.128 | -3.483 | -4.426 | 0 | 0.351 | 3.375 |
Cash and Short Term Investments
| 739.867 | 724.689 | 1,009.321 | 793.165 | 368.812 | 442.858 | 369.95 | 258.552 | 125.161 | 99.55 | 185.052 | 119.469 | 64.09 | 131.871 |
Net Receivables
| 361.431 | 320.733 | 187.591 | 222.73 | 165.028 | 181.708 | 158.004 | 76.008 | 53.093 | 25.379 | 167.765 | 42.724 | 66.426 | 64.54 |
Inventory
| 773.762 | 612.6 | 594.415 | 579.689 | 454.669 | 400.173 | 299.002 | 146.425 | 143.472 | 163.866 | 185.711 | 156.454 | 156.765 | 124.686 |
Other Current Assets
| 96.395 | 101.354 | 103.055 | 106.815 | 197.319 | 111.659 | 246.174 | 278.441 | 24.993 | 12.263 | 8.023 | 19.884 | 91.07 | 68.621 |
Total Current Assets
| 1,971.456 | 1,759.375 | 1,894.382 | 1,702.398 | 1,134.102 | 1,136.397 | 1,073.13 | 777.339 | 346.719 | 314.516 | 550.255 | 338.531 | 370.778 | 325.178 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 1,888.111 | 1,900.342 | 1,801.928 | 1,614.682 | 1,144.988 | 927.366 | 738.765 | 358.736 | 290.215 | 260.398 | 259.559 | 397.595 | 343.788 | 275.39 |
Goodwill
| 0 | 0 | 0 | 22.741 | 22.741 | 51.002 | 51.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 234.67 | 206.246 | 172.493 | 201.698 | 224.671 | 183.245 | 175.419 | 107.456 | 108.615 | 66.568 | 52.445 | 94.992 | 96.589 | 95.661 |
Goodwill and Intangible Assets
| 234.67 | 206.246 | 172.493 | 224.438 | 247.411 | 234.246 | 226.421 | 107.456 | 108.615 | 66.568 | 52.445 | 94.992 | 96.589 | 95.661 |
Long Term Investments
| 172.96 | 46.675 | 82.736 | -51.791 | 275.424 | 83.264 | 165.96 | 258.377 | 189.693 | 153.155 | 88.333 | 8.136 | 3.356 | 3.75 |
Tax Assets
| 41.158 | 42.674 | 123.142 | 33.271 | 45.463 | 29.53 | 19.438 | 2.683 | 3.524 | 3.251 | 3.216 | 2.006 | 3.003 | 4.709 |
Other Non-Current Assets
| 342.866 | 468.204 | 344.776 | 478.496 | 215.335 | 203.166 | 47.369 | 9.115 | 16.526 | 29.756 | 13.077 | 23.426 | 14.067 | 5.278 |
Total Non-Current Assets
| 2,679.765 | 2,664.141 | 2,525.076 | 2,299.098 | 1,928.621 | 1,477.572 | 1,197.952 | 736.367 | 608.572 | 513.128 | 416.631 | 526.156 | 460.803 | 384.789 |
Total Assets
| 4,651.221 | 4,423.516 | 4,419.458 | 4,001.495 | 3,062.723 | 2,613.97 | 2,271.082 | 1,513.706 | 955.292 | 827.644 | 966.885 | 864.686 | 831.581 | 709.967 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 633.916 | 390.988 | 208.422 | 389.053 | 372.059 | 308.937 | 262.454 | 154.667 | 118.049 | 118.409 | 206.314 | 156.509 | 143.314 | 132.698 |
Short Term Debt
| 479.057 | 545.067 | 519.089 | 425.867 | 709.432 | 429.443 | 427.949 | 155.029 | 67 | 30 | 159 | 164.65 | 202.37 | 132.96 |
Tax Payables
| 13.499 | 25.455 | 72.124 | 34.62 | 7.57 | 16.031 | 9.787 | 9.443 | 6.637 | 5.991 | 10.952 | 11.008 | 9.664 | 10.709 |
Deferred Revenue
| 0 | 153.094 | 194.919 | 248.874 | 88.334 | 84.893 | 9.787 | 29.278 | 24.531 | 22.824 | 25.893 | 29.257 | 36.672 | 38.915 |
Other Current Liabilities
| 459.49 | 263.664 | 389.745 | 297.281 | 67.191 | 37.094 | 69.459 | 21.004 | -2.618 | 22.358 | -4.014 | 15.468 | 33.22 | 53.919 |
Total Current Liabilities
| 1,585.961 | 1,378.267 | 1,362.219 | 1,146.82 | 1,112.343 | 876.398 | 779.437 | 340.142 | 213.599 | 176.758 | 398.146 | 376.893 | 388.567 | 330.286 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 663.966 | 759.65 | 705.597 | 755.339 | 142.849 | 123.44 | 107.906 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 83.184 | 81.481 | 70.568 | 48.67 | 24.238 | 18.493 | 18.935 | 5.595 | 5.595 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 21.822 | 13.589 | 102.988 | 67.315 | 50.307 | 22.273 | 19.796 | 0.607 | 0 | 0 | 0 | 0 | 0.088 | 0.844 |
Other Non-Current Liabilities
| 4.846 | 86.327 | -65.722 | 4.846 | 39.189 | 23.339 | 4.846 | 4.846 | 5.074 | 5.074 | 4.398 | 0.35 | 0.35 | 0.367 |
Total Non-Current Liabilities
| 773.817 | 859.565 | 883.999 | 876.17 | 187.899 | 169.052 | 151.483 | 11.049 | 10.669 | 5.074 | 4.398 | 0.35 | 0.438 | 1.21 |
Total Liabilities
| 2,359.779 | 2,237.832 | 2,246.218 | 2,022.99 | 1,300.241 | 1,045.45 | 930.92 | 351.191 | 224.268 | 181.831 | 402.545 | 377.243 | 389.005 | 331.497 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.464 | 0.473 | 0 | 0 |
Common Stock
| 218.755 | 213.407 | 213.378 | 151.317 | 149.609 | 149.682 | 149.134 | 120 | 90 | 90 | 90 | 90 | 90 | 90 |
Retained Earnings
| 1,273.013 | 1,210.596 | 1,234.32 | 937.352 | 811.848 | 668.271 | 553.068 | 479.438 | 434.761 | 356.634 | 285.051 | 212.197 | 158.147 | 128.392 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 101.4 | 77.617 | 33.56 | 11.081 | 17.244 | 9.892 | 165.316 | 164.522 | -0.464 | -0.473 | 0 | 0 |
Other Total Stockholders Equity
| 700.977 | 672.249 | 637.29 | 662.816 | 620.264 | 546.189 | 494.952 | 506.963 | 165.316 | 164.522 | 155.537 | 162.218 | 175.587 | 143.812 |
Total Shareholders Equity
| 2,192.745 | 2,096.252 | 2,084.987 | 1,751.484 | 1,551.721 | 1,364.142 | 1,197.154 | 1,116.293 | 690.077 | 611.155 | 535.043 | 463.942 | 423.734 | 362.204 |
Total Equity
| 2,291.443 | 2,185.684 | 2,173.24 | 1,978.505 | 1,762.481 | 1,568.52 | 1,340.162 | 1,162.515 | 731.023 | 645.812 | 564.34 | 487.443 | 442.576 | 378.47 |
Total Liabilities & Shareholders Equity
| 4,651.221 | 4,423.516 | 4,419.458 | 4,001.495 | 3,062.723 | 2,613.97 | 2,271.082 | 1,513.706 | 955.292 | 827.644 | 966.885 | 864.686 | 831.581 | 709.967 |